136 related articles for article (PubMed ID: 9826556)
21. Epigenetic silencing of cell adhesion molecule 1 in different cancer progenitor cells of transgenic c-Myc and c-Raf mouse lung tumors.
Reamon-Buettner SM; Borlak J
Cancer Res; 2008 Sep; 68(18):7587-96. PubMed ID: 18794147
[TBL] [Abstract][Full Text] [Related]
22. Raf and RhoA cooperate to transform intestinal epithelial cells and induce growth resistance to transforming growth factor beta.
Du J; Jiang B; Coffey RJ; Barnard J
Mol Cancer Res; 2004 Apr; 2(4):233-41. PubMed ID: 15140945
[TBL] [Abstract][Full Text] [Related]
23. The effect of transfection with the oncogenes H-ras and c-myc on the radiosensitivity of a mink epithelial cell line.
Russell J; Khan MZ; Kerr DJ; Spandidos DA
Radiat Res; 1992 Apr; 130(1):113-6. PubMed ID: 1561309
[TBL] [Abstract][Full Text] [Related]
24. A cell culture model system for genetic analyses of the cell cycle by targeted homologous recombination.
Prouty SM; Hanson KD; Boyle AL; Brown JR; Shichiri M; Follansbee MR; Kang W; Sedivy JM
Oncogene; 1993 Apr; 8(4):899-907. PubMed ID: 8455944
[TBL] [Abstract][Full Text] [Related]
25. A modest reduction in c-myc expression has minimal effects on cell growth and apoptosis but dramatically reduces susceptibility to Ras and Raf transformation.
Bazarov AV; Adachi S; Li SF; Mateyak MK; Wei S; Sedivy JM
Cancer Res; 2001 Feb; 61(3):1178-86. PubMed ID: 11221849
[TBL] [Abstract][Full Text] [Related]
26. Apoptosis-prone phenotype of human colon carcinoma cells with a high level amplification of the c-myc gene.
Donzelli M; Bernardi R; Negri C; Prosperi E; Padovan L; Lavialle C; Brison O; Scovassi AI
Oncogene; 1999 Jan; 18(2):439-48. PubMed ID: 9927200
[TBL] [Abstract][Full Text] [Related]
27. [Drug resistance, oncogenes, and anti-oncogenes in epithelial tumors].
Riva-Lavieille C
Bull Cancer; 1994 Dec; 81 Suppl 2():105s-111s. PubMed ID: 7727855
[TBL] [Abstract][Full Text] [Related]
28. Identification of frequent novel genetic alterations in small cell lung carcinoma.
Levin NA; Brzoska P; Gupta N; Minna JD; Gray JW; Christman MF
Cancer Res; 1994 Oct; 54(19):5086-91. PubMed ID: 7923122
[TBL] [Abstract][Full Text] [Related]
29. The role of c-myc in regulating mdr1 gene expression in tumor cell line KB.
He Y; Zhang J; Zhang J; Yuan Y
Chin Med J (Engl); 2000 Sep; 113(9):848-51. PubMed ID: 11776085
[TBL] [Abstract][Full Text] [Related]
30. High c-myc amplification level contributes to the tumorigenic phenotype of the human breast carcinoma cell line SW 613-S.
Lavialle C; Modjtahedi N; Cassingena R; Brison O
Oncogene; 1988 Sep; 3(3):335-9. PubMed ID: 3060796
[TBL] [Abstract][Full Text] [Related]
31. [Suppression of c-myc expression by interference RNA in HepG2 hepatocellular carcinoma cells].
Xu Y; Wang YH; Gao JD; Ye J; Zhu HX; Xu NZ; Wang XY; Sun ZT
Zhonghua Zhong Liu Za Zhi; 2004 Aug; 26(8):458-60. PubMed ID: 15555332
[TBL] [Abstract][Full Text] [Related]
32. A novel retinoic acid receptor beta isoform and retinoid resistance in lung carcinogenesis.
Petty WJ; Li N; Biddle A; Bounds R; Nitkin C; Ma Y; Dragnev KH; Freemantle SJ; Dmitrovsky E
J Natl Cancer Inst; 2005 Nov; 97(22):1645-51. PubMed ID: 16288117
[TBL] [Abstract][Full Text] [Related]
33. Comparison of amplified and unamplified c-myc gene structure and expression in human small cell lung carcinoma cell lines.
Seifter EJ; Sausville EA; Battey J
Cancer Res; 1986 Apr; 46(4 Pt 2):2050-5. PubMed ID: 3004717
[TBL] [Abstract][Full Text] [Related]
34. Evidence supporting a signal transduction pathway leading to the radiation-resistant phenotype in human tumor cells.
Pirollo KF; Hao Z; Rait A; Ho CW; Chang EH
Biochem Biophys Res Commun; 1997 Jan; 230(1):196-201. PubMed ID: 9020045
[TBL] [Abstract][Full Text] [Related]
35. Proto-oncogene expression in human glomerular diseases.
Takemura T; Okada M; Akano N; Murakami K; Hino S; Yagi K; Takekoshi Y; Yoshioka K
J Pathol; 1996 Mar; 178(3):343-51. PubMed ID: 8778342
[TBL] [Abstract][Full Text] [Related]
36. Loss of expression of death-inducing signaling complex (DISC) components in lung cancer cell lines and the influence of MYC amplification.
Shivapurkar N; Reddy J; Matta H; Sathyanarayana UG; Huang CX; Toyooka S; Minna JD; Chaudhary PM; Gazdar AF
Oncogene; 2002 Dec; 21(55):8510-4. PubMed ID: 12466971
[TBL] [Abstract][Full Text] [Related]
37. Regulation of human telomerase activity: repression by normal chromosome 3 abolishes nuclear telomerase reverse transcriptase transcripts but does not affect c-Myc activity.
Ducrest AL; Amacker M; Mathieu YD; Cuthbert AP; Trott DA; Newbold RF; Nabholz M; Lingner J
Cancer Res; 2001 Oct; 61(20):7594-602. PubMed ID: 11606399
[TBL] [Abstract][Full Text] [Related]
38. Oncogene amplification and chromosomal abnormalities in small cell lung cancer.
Ibson JM; Waters JJ; Twentyman PR; Bleehen NM; Rabbitts PH
J Cell Biochem; 1987 Apr; 33(4):267-88. PubMed ID: 3034934
[TBL] [Abstract][Full Text] [Related]
39. Transforming growth factor-beta is an endogenous radioresistance factor in the esophageal adenocarcinoma cell line OE-33.
Kim AH; Lebman DA; Dietz CM; Snyder SR; Eley KW; Chung TD
Int J Oncol; 2003 Dec; 23(6):1593-9. PubMed ID: 14612931
[TBL] [Abstract][Full Text] [Related]
40. Adenovirus-mediated mda-7 gene expression radiosensitizes non-small cell lung cancer cells via TP53-independent mechanisms.
Kawabe S; Nishikawa T; Munshi A; Roth JA; Chada S; Meyn RE
Mol Ther; 2002 Nov; 6(5):637-44. PubMed ID: 12409262
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]